Lumibird's 2025 Results: Upward Performance

In 2025, the Lumibird Group, a leader in laser technologies, posted strong growth in its financial results. Revenue reached €225.6 million, an increase of 8.9% compared to the previous year. EBITDA saw a significant rise of 38.3%, reaching €45.6 million, with a margin of 20.2% of revenue.

The Photonics and Medical divisions contributed to this growth. The Photonics division recorded a 14.1% increase in revenue, driven by its Defense and Space activities. The Medical division experienced more modest growth of 4.1% but maintained strong margins.

Current operating income increased by 71.7%, reaching €25.7 million, while net income more than doubled to €14.0 million. Despite free cash flow of €13.1 million, cash reserves decreased slightly, primarily due to investments and debt repayments.

Looking ahead, Lumibird anticipates continued growth and high margins through controlled operating costs.